Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Metcalfe

Showing results (201-210 of 208) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 208 results.
Cancer Research|May 17, 2003
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancerAlison M Dunning, Peter D Ellis, Simon McBride, et al.
Pilot and Feasibility Studies|December 4, 2018
Correction to: The help for people with money, employment or housing problems (HOPE) intervention: pilot randomised trial with mixed methods feasibility researchM C Barnes, A M Haase, L J Scott, et al.
Pilot and Feasibility Studies|November 22, 2018
The help for people with money, employment or housing problems (HOPE) intervention: pilot randomised trial with mixed methods feasibility researchM C Barnes, A M Haase, L J Scott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancerLaura E Lantry, Enrico Cappelletti, Mary Ellen Maddalena, et al.
British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.
British Journal of Cancer|May 29, 2014
Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)E L Turner, C Metcalfe, J L Donovan, et al.
Nature Communications|November 5, 2024
Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancerM T Herrera-Abreu, J Guan, U Khalid, et al.
The New England Journal of Medicine|September 15, 2016
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate CancerJ L Donovan, F C Hamdy, J A Lane, et al.
Pageof 21

Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
Cancer Research|May 17, 2003
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancerAlison M Dunning, Peter D Ellis, Simon McBride, et al.
Pilot and Feasibility Studies|December 4, 2018
Correction to: The help for people with money, employment or housing problems (HOPE) intervention: pilot randomised trial with mixed methods feasibility researchM C Barnes, A M Haase, L J Scott, et al.
Pilot and Feasibility Studies|November 22, 2018
The help for people with money, employment or housing problems (HOPE) intervention: pilot randomised trial with mixed methods feasibility researchM C Barnes, A M Haase, L J Scott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancerLaura E Lantry, Enrico Cappelletti, Mary Ellen Maddalena, et al.
British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.
British Journal of Cancer|May 29, 2014
Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)E L Turner, C Metcalfe, J L Donovan, et al.
Nature Communications|November 5, 2024
Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancerM T Herrera-Abreu, J Guan, U Khalid, et al.
The New England Journal of Medicine|September 15, 2016
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate CancerJ L Donovan, F C Hamdy, J A Lane, et al.
Pageof 21